Efficacy of Methotrexate in Real-world Management of Giant Cell Arteritis: A Case-control Study.

CONCLUSION: In this large single-institution cohort, the addition of MTX to GC decreased the rate of subsequent relapse by nearly 2-fold compared to patients taking GC alone. MTX may be considered as adjunct therapy in patients with GCA to decrease the risk of further relapse events.
PMID: 30647171 [PubMed - as supplied by publisher]

Source: J Rheumatol - January 15, 2019 Category: Rheumatology Authors: Koster MJ, Yeruva K, Crowson CS, Muratore F, Labarca C, Warrington KJ Tags: J Rheumatol Source Type: research